IBDEI20K ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33738,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33738,1,2,0)
 ;;=2^Amb BP Review,Intrp & Rpt
 ;;^UTILITY(U,$J,358.3,33738,1,3,0)
 ;;=3^93790
 ;;^UTILITY(U,$J,358.3,33739,0)
 ;;=93770^^153^1698^5^^^^1
 ;;^UTILITY(U,$J,358.3,33739,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33739,1,2,0)
 ;;=2^Measure Venous Pressure
 ;;^UTILITY(U,$J,358.3,33739,1,3,0)
 ;;=3^93770
 ;;^UTILITY(U,$J,358.3,33740,0)
 ;;=J0636^^153^1699^1^^^^1
 ;;^UTILITY(U,$J,358.3,33740,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33740,1,2,0)
 ;;=2^Calcitriol per 0.1 MCG
 ;;^UTILITY(U,$J,358.3,33740,1,3,0)
 ;;=3^J0636
 ;;^UTILITY(U,$J,358.3,33741,0)
 ;;=J0713^^153^1699^2^^^^1
 ;;^UTILITY(U,$J,358.3,33741,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33741,1,2,0)
 ;;=2^Ceftazidime per 500 MG
 ;;^UTILITY(U,$J,358.3,33741,1,3,0)
 ;;=3^J0713
 ;;^UTILITY(U,$J,358.3,33742,0)
 ;;=J1160^^153^1699^5^^^^1
 ;;^UTILITY(U,$J,358.3,33742,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33742,1,2,0)
 ;;=2^Digoxin up to 0.5 MG
 ;;^UTILITY(U,$J,358.3,33742,1,3,0)
 ;;=3^J1160
 ;;^UTILITY(U,$J,358.3,33743,0)
 ;;=Q0138^^153^1699^9^^^^1
 ;;^UTILITY(U,$J,358.3,33743,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33743,1,2,0)
 ;;=2^Ferumoxytol,Non-ESRD,1 MG
 ;;^UTILITY(U,$J,358.3,33743,1,3,0)
 ;;=3^Q0138
 ;;^UTILITY(U,$J,358.3,33744,0)
 ;;=Q0139^^153^1699^8^^^^1
 ;;^UTILITY(U,$J,358.3,33744,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33744,1,2,0)
 ;;=2^Ferumoxytol,ESRD Use,1 MG
 ;;^UTILITY(U,$J,358.3,33744,1,3,0)
 ;;=3^Q0139
 ;;^UTILITY(U,$J,358.3,33745,0)
 ;;=J1580^^153^1699^10^^^^1
 ;;^UTILITY(U,$J,358.3,33745,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33745,1,2,0)
 ;;=2^Garamycin Gentamicin up to 80 MG
 ;;^UTILITY(U,$J,358.3,33745,1,3,0)
 ;;=3^J1580
 ;;^UTILITY(U,$J,358.3,33746,0)
 ;;=J1644^^153^1699^12^^^^1
 ;;^UTILITY(U,$J,358.3,33746,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33746,1,2,0)
 ;;=2^Heparin Sodium per 1000 Units
 ;;^UTILITY(U,$J,358.3,33746,1,3,0)
 ;;=3^J1644
 ;;^UTILITY(U,$J,358.3,33747,0)
 ;;=96374^^153^1699^13^^^^1
 ;;^UTILITY(U,$J,358.3,33747,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33747,1,2,0)
 ;;=2^IV Push,Ther/Proph/Diag
 ;;^UTILITY(U,$J,358.3,33747,1,3,0)
 ;;=3^96374
 ;;^UTILITY(U,$J,358.3,33748,0)
 ;;=J1750^^153^1699^14^^^^1
 ;;^UTILITY(U,$J,358.3,33748,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33748,1,2,0)
 ;;=2^Iron Dextran 50 MG
 ;;^UTILITY(U,$J,358.3,33748,1,3,0)
 ;;=3^J1750
 ;;^UTILITY(U,$J,358.3,33749,0)
 ;;=B4189^^153^1699^15^^^^1
 ;;^UTILITY(U,$J,358.3,33749,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33749,1,2,0)
 ;;=2^Parenteral NutrSol 10-15 g Protein
 ;;^UTILITY(U,$J,358.3,33749,1,3,0)
 ;;=3^B4189
 ;;^UTILITY(U,$J,358.3,33750,0)
 ;;=J3370^^153^1699^16^^^^1
 ;;^UTILITY(U,$J,358.3,33750,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33750,1,2,0)
 ;;=2^Vancomycin HCL 500 MG
 ;;^UTILITY(U,$J,358.3,33750,1,3,0)
 ;;=3^J3370
 ;;^UTILITY(U,$J,358.3,33751,0)
 ;;=J0882^^153^1699^3^^^^1
 ;;^UTILITY(U,$J,358.3,33751,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33751,1,2,0)
 ;;=2^Darbepoetin Alfa,ESRD Use,1 MCG
 ;;^UTILITY(U,$J,358.3,33751,1,3,0)
 ;;=3^J0882
 ;;^UTILITY(U,$J,358.3,33752,0)
 ;;=J0881^^153^1699^4^^^^1
 ;;^UTILITY(U,$J,358.3,33752,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33752,1,2,0)
 ;;=2^Darbepoetin Alfa,Non-ESRD,1 MCG
 ;;^UTILITY(U,$J,358.3,33752,1,3,0)
 ;;=3^J0881
 ;;^UTILITY(U,$J,358.3,33753,0)
 ;;=J0885^^153^1699^7^^^^1
 ;;^UTILITY(U,$J,358.3,33753,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33753,1,2,0)
 ;;=2^Epoetin Alfa,Non-ESRD,1000 Units
 ;;^UTILITY(U,$J,358.3,33753,1,3,0)
 ;;=3^J0885
